Millennium Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-78,300
| Closed | -$2.32M | – | 6854 |
|
|
2023
Q4 | $2.32M | Buy |
+78,300
| New | +$1.56M | ﹤0.01% | 3487 |
|
|
2023
Q3 | – | Sell |
-100,000
| Closed | -$1.89M | – | 6727 |
|
|
2023
Q2 | $1.89M | Sell |
100,000
-544,500
| -84% | -$6.43M | ﹤0.01% | 3529 |
|
|
2023
Q1 | $2.48M | Buy |
644,500
+344,500
| +115% | +$1.47M | ﹤0.01% | 3230 |
|
|
2022
Q4 | $1.49M | Sell |
300,000
-305,000
| -50% | -$1.65M | ﹤0.01% | 3811 |
|
|
2022
Q3 | $2.89M | Buy |
605,000
+405,000
| +203% | +$2.13M | ﹤0.01% | 3426 |
|
|
2022
Q2 | $900K | Buy |
200,000
+100,000
| +100% | +$434K | ﹤0.01% | 4465 |
|
|
2022
Q1 | $476K | Buy |
+100,000
| New | +$554K | ﹤0.01% | 5163 |
|
|
2021
Q4 | – | Sell |
-100,000
| Closed | -$567K | – | 7555 |
|
|
2021
Q3 | $567K | Hold |
100,000
| – | – | ﹤0.01% | 5231 |
|
|
2021
Q2 | $659K | Buy |
100,000
+50,000
| +100% | +$349K | ﹤0.01% | 5055 |
|
|
2021
Q1 | $405K | Buy |
+50,000
| New | +$408K | ﹤0.01% | 5001 |
|
|
2019
Q4 | – | Sell |
-480,000
| Closed | -$1.16M | – | 4728 |
|
|
2019
Q3 | $1.16M | Hold |
480,000
| – | – | ﹤0.01% | 2763 |
|
|
2019
Q2 | $1.04M | Sell |
480,000
-993,400
| -67% | -$2.35M | ﹤0.01% | 2787 |
|
|
2019
Q1 | $3.99M | Buy |
1,473,400
+342,300
| +30% | +$1.48M | 0.01% | 1915 |
|
|
2018
Q4 | $5.43M | Buy |
+1,131,100
| New | +$6.86M | 0.01% | 1533 |
|
|
2015
Q1 | – | Sell |
-35,800
| Closed | -$218K | – | 4225 |
|
|
2014
Q4 | $218K | Buy |
+35,800
| New | +$327K | ﹤0.01% | 3575 |
|
Other funds holding IMGN
Millennium Management's IMGN Position: Q1 2024 in Review
Millennium Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,473,868 shares — an estimated $133M sold.
Millennium Management first reported a position in IMGN in Q3 2013 and held it in 41 quarters. The position peaked at $133M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Millennium Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 4,473,868 Immunogen Inc shares in Q1 2024, an estimated $133M.
- Millennium Management first reported a position in Immunogen Inc in Q3 2013 and held it in 41 quarters.
- Millennium Management's Immunogen Inc position peaked at $133M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.